Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses

Persistence of HIV through integration into host DNA in CD4+ T cells presents a major barrier to virus eradication. Viral integration may be curtailed when CD8+ T cells are triggered to kill infected CD4+ T cells through recognition of histocompatibility leukocyte antigen (HLA) class I-bound peptide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell reports (Cambridge) 2021-05, Vol.35 (6), p.109103-109103, Article 109103
Hauptverfasser: Yang, Hongbing, Llano, Anuska, Cedeño, Samandhy, von Delft, Annette, Corcuera, Angelica, Knox, Andrew, Leneghan, Darren B., Frater, John, Stöhr, Wolfgang, Fidler, Sarah, Mothe, Beatriz, Mak, Johnson, Brander, Christian, Ternette, Nicola, Dorrell, Lucy, Sandström, Eric, Darbyshire, Janet, Post, Frank, Conlon, Christopher, Anderson, Jane, Maini, Mala, Peto, Timothy, Sasieni, Peter, Miller, Veronica, Weller, Ian, Babiker, Abdel, Pett, Sarah, Pace, Matthew, Olejniczak, Natalia, Brown, Helen, Robinson, Nicola, Kopycinski, Jakub, Hanke, Tomáš, Crook, Alison, Kaye, Steven, McClure, Myra, Erlwein, Otto, Lovell, Andrew, Khan, Maryam, Bennett, Rachel, Sy, Aminata, Gregory, Adam, Hudson, Fleur, Russell, Charlotte, Wood, Gemma, Box, Hanna, Kingsley, Cherry, Topping, Katie, Wills, Mark, Fun, Axel, Bandara, Mikaila, Kelly, Damian, Rauchenberger, Mary, Sowunmi, Yinka, Shidfar, Shaadi, Hague, Dominic, Nelson, Mark, Cerrone, Maddalena, Castrillo Martinez, Nadia, Barber, Tristan, Schoolmeesters, Alexandra, Weaver, Christine, Thunder, Orla, Rowlands, Jane, Higgs, Christopher, Fedele, Serge, Bracchi, Margherita, Bourke, Peter, Lawrenson, Gaynor, Fiorino, Marzia, Lukha, Hinal, Kinloch-de Loes, Sabine, Ngwu, Nnenna, Byrne, Patrick, Cuthbertson, Zoe, Jones, Martin, Fernandez, Tina, Clarke, Amanda, Fisher, Martin, Gleig, Rebecca, Trevitt, Vittorio, Fitzpatrick, Colin, Adams, Tanya, Finnerty, Fiounnuala, Thornhill, John, Lewis, Heather, Kuldanek, Kristin, Fox, Julie, Uzu, Hiromi, Lee, Ming, O’Rourke, Patrick, Jendrulek, Isabel, Zarko Flynn, Taras, Taylor, Mark, Manuel Tiraboschi, Juan, Murray, Tammy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Persistence of HIV through integration into host DNA in CD4+ T cells presents a major barrier to virus eradication. Viral integration may be curtailed when CD8+ T cells are triggered to kill infected CD4+ T cells through recognition of histocompatibility leukocyte antigen (HLA) class I-bound peptides derived from incoming virions. However, this has been reported only in individuals with “beneficial” HLA alleles that are associated with superior HIV control. Through interrogation of the pre-integration immunopeptidome, we obtain proof of early presentation of a virion-derived HLA-A∗02:01-restricted epitope, FLGKIWPSH (FH9), located in Gag Spacer Peptide 2 (SP2). FH9-specific CD8+ T cell responses are detectable in individuals with primary HIV infection and eliminate HIV-infected CD4+ T cells prior to virus production in vitro. Our data show that non-beneficial HLA class I alleles can elicit an effective antiviral response through early presentation of HIV virion-derived epitopes and also demonstrate the importance of SP2 as an immune target. [Display omitted] •CD8+ T cell recognition of incoming HIV antigens leads to efficient virus control•HLA-I-bound HIV peptides from incoming virions are identifiable by mass spectrometry•Gag Spacer Peptide 2 elicits killing of CD4+ T cells early in the viral life cycle•Early CD8+ T cell killing is not dependent on protective HLA class I alleles Unbiased approaches to deciphering immune control mechanisms in people with HIV may help in the search for a cure. Yang et al. use proteomics to identify viral peptides presented early in the viral life cycle and show that Gag Spacer Peptide 2 recognition triggers efficient CD8+ T cell killing.
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2021.109103